EP Patent

EP2583758A1 — Manually operable fluid dispensing device

Assigned to Lek Pharmaceuticals dd · Expires 2013-04-24 · 13y expired

What this patent protects

Manually operable fluid dispensing device, comprising: a housing (10a, 10b; 110; 210), an actuation member (30; 130; 230) attached to the housing (10a, 10b; 110; 210) so that it can be manually actuated in an actuation direction, a movable member (20; 120; 220) being movable in a…

USPTO Abstract

Manually operable fluid dispensing device, comprising: a housing (10a, 10b; 110; 210), an actuation member (30; 130; 230) attached to the housing (10a, 10b; 110; 210) so that it can be manually actuated in an actuation direction, a movable member (20; 120; 220) being movable in a direction substantially perpendicular to the actuation direction of the actuation member (30; 130; 230) in order to enable a discharge of fluid from the fluid dispensing device, a conversion mechanism for converting a movement of the actuation member (30; 130; 230) into a movement of the moveable member, wherein the conversion mechanism includes a flexible member (40; 140; 240) being elastically deformable, the flexible member (40; 140; 240) being in engagement with the movable member (20; 120; 220) and supported by the actuation member (30; 130; 230) such that it is able to elastically deform in connection with an actuation of the actuation member (30; 130; 230), the flexible member (40; 140; 240) applying a force onto the movable member (20; 120; 220) for moving the movable member (20; 120; 220).

Drugs covered by this patent

Patent Metadata

Patent number
EP2583758A1
Jurisdiction
EP
Classification
Expires
2013-04-24
Drug substance claim
No
Drug product claim
No
Assignee
Lek Pharmaceuticals dd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.